Special Notice Circulation will be published twice each month beginning in January 1995. This will allow us to publish high-quality manuscripts dealing with cardiovascular problems in a more timely manner and in a smaller journal, which will best serve the general cardiovascular community. The angiotensin I-converting enzyme (ACE) is a key component of the renin-angiotensin system thought to be important in the pathogenesis of hypertension and cardiovascular disease. Deletion polymorphism in the ACE gene may be a risk factor for myocardial infarction in the Caucasian population. However, this finding has not yet been investigated in the Japanese population. A 287-bp insertion/deletion polymorphism in intron 16 of the ACE gene was examined by polymerase chain reaction in a cross-sectional study of 100 healthy subjects and 178 patients with coronary artery disease (CAD) (70 angina pectoris, 108 myocardial infarction), whose serum ACE levels were concomitantly measured. Polymorphism of the ACE gene was characterized by three genotypes: two deletion alleles (genotype DD), two insertion alleles (genotype II), and heterozygous alleles (genotype ID). No differences could be detected among the three genotypes for total cholesterol, HDL cholesterol, and body mass index. Serum ACE levels were 11.4+2.7, 14.5±3.5, and 16.6±4.6 IU/mL for genotypes II, ID, and DD, respectively. In the study population, the genotype DD was more closely associated with CAD than the other two genotypes (ID and II). The frequency of deletion alleles was higher (0.58) in the CAD group than in healthy control subjects (0.42) (P<.05) . Furthermore, multi-vessel disease was more strongly associated with deletion alleles than with insertion alleles (P<.05). A deletion polymorphism of the ACE gene is associated with serum ACE activity and increased risk for CAD in the Japanese. myocardial infarction, intravenous thrombolytic agents fail to achieve early infarction artery patency in 15% to 50% of patients. We tested the hypothesis that immediate balloon angioplasty applied in this setting would improve ventricular function and clinical outcome at 30 days compared with medical management alone. One hundred fifty-one patients with first anterior wall infarction treated with any accepted intravenous thrombolytic regimen and angiographically demonstrated to have an occluded infarct vessel within 8 hours of chest pain onset were randomized to medical treatment only or medical treatment and balloon angioplasty. Angioplasty was technically successful in 72 randomized patients (92%). While there was no difference in resting ejection fraction (40±11% versus 39±12%), with exercise patients in the angioplasty group had an increased ejection fraction (43±15% versus 38±13%, respectively; P=.04). Death or severe heart failure occurred in 6% and 17% of the angioplasty and medical treatment groups, respectively (P=.05). When applied to patients with first anterior infarction, rescue angioplasty appears to be useful in the prevention of death or severe heart failure with improvement in exercise, but not resting, ejection fraction. Little is known about how best to manage cardiac tamponade when it complicates acute proximal aortic dissection. We retrospectively identified 10 patients presenting to our hospital over a 13-year period who were diagnosed with both aortic dissection and cardiac tamponade. Three presented with fatal electromechanical dissociation and seven were hypotensive or normotensive on presentation. Of this latter group three of four undergoing successful pericardiocentesis died, while none of those having either no pericardiocentesis or an unsuccessful pericardiocentesis died. These observations raise the possibility that in patients with cardiac tamponade complicating aortic dissection pericardiocentesis may be harmful rather than beneficial.
Congenital Heart Disease
Origin lacZ reporter genes were injected directly into the ventricular myocardium of adult domestic swine for evaluation of reporter gene expression. This procedure did not affect regional myocardial function as assessed by systolic wall thickening using ultrasonic crystals. Luciferase activity was detected 3 days after injection, increased markedly at 7 days, and then declined progressively at 14 and 21 days. Luciferase production was comparable in the right and left ventricular walls and increased with increasing amounts of virus. The injection of 200 jug of plasmid DNA (pRSVL) produced significant levels of luciferase; however, when normalized to the number of genes injected, the adenovirus was 140 000 times more efficient than plasmid DNA. Histochemical analysis of /-galactosidase activity demonstrated that nearly all (>95%) of the stained cells were cardiomyocytes, but prominent leukocytic infiltration was also documented. This study evaluates for the first time the potential of direct A38 intramyocardial injection of replication-deficient adenovirus as a method of introducing recombinant genes into the cardiomyocytes of a large animal species with relevance to human physiology. We used an ex vivo perfusion model to study the growth of arterial thrombus onto preformed thrombus. We hypothesized that direct thrombin inhibition would block acute thrombus growth better than current medical therapies. Thrombus growth as measured by deposition (D) of`tIn-labeled platelets (P) (x 106/cm2) and`PI-labeled fibrinogen (F) (x 1012 molecules/cm2) was mildly but not significantly reduced by aspirin (1034±92 and 436-+-78, respectively) compared with baseline (1113±67 and 545±52, respectively). Inhibition of thrombus growth with heparin was dose dependent. Recombinant hirudin profoundly inhibited growth of thrombus (PD, 30±12; FD, 109±21) significantly more than even the highest dosage of heparin (250 IU/kg per hour). This study suggests that growth of a thrombus on a vascular surface covered with fresh thrombus appears to be primarily thrombin mediated. 2439 We studied the time course of coronary vascular endothelial injury after 1 hour of coronary artery ligation in dogs killed at 1 hour, 48 hours, 2 weeks, or 9 weeks of reperfusion. At 1 hour and 48 hours of reperfusion we observed abnormal endotheliumdependent relaxation of coronary vascular rings excised from the ischemic/reperfused epicardial coronary artery, and increased regional protein leak, an index of coronary microvascular permeability, in the previously ischemic myocardium. There were histological abnormalities in the endothelium in the epicardial coronary artery and microvasculature at 48 hours of reperfusion. However, nearly complete functional and complete histological healing occurred within 2 weeks, and complete functional healing occurred within 9 weeks of reperfusion. Data from in vitro and in vivo experimental models have shown that certain waveforms are not only more efficient at defibrillation but also affect myocardial function to a different extent than others. However, to date the relation between defibrillation efficacy and myocardial injury of clinically used waveforms has not been extensively studied. We investigated whether the higher efficacy of asymmetrical biphasic shocks may also be associated with more-injurious effects and, therefore, may not provide a true biological advantage compared with monophasic waveforms. In the canine model, myocardial lactate extraction rate and hemodynamic performance as measures of defibrillation injury were significantly more suppressed after two monophasic shocks in sinus rhythm compared with two biphasic shocks of the same energy. However, the defibrillation thresholds were significantly lower for biphasic shocks. Given this higher defibrillation efficacy as well as the less-injurious effects on myocardial oxidative metabolism and hemodynamic function, the "therapeutic range" of biphasic waveforms is better, which might provide an important long-term benefit in patients receiving frequent shocks from implantable cardioverter-defibrillators. 
Role of Protein
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Congestive heart failure is a common, highly lethal cardiovascular disorder claiming over 200 000 lives a year in the United States alone. Some 50% of the deaths in heart failure patients are sudden, and most of these are probably the result of ventricular tachyarrhythmias. Methods designed to identify patients at risk have been remarkably unrewarding, as have attempts to intervene and prevent sudden death in these patients. The failure to impact favorably on the incidence of sudden death in heart failure patients stems largely from a lack of understanding of the underlying mechanisms of arrhythmogenesis. This article explores the role of abnormalities of ventricular repolarization in heart failure patients. We will examine evidence for the hypothesis that alteration of repolarizing K' channel expression in failing myocardium predisposes to abnormalities in repolarization that are arrhythmogenic. The possible utility of novel electrophysiological and ECG measures of altered ventricular repolarization will be explored. Understanding the mechanism of sudden death in heart failure may lead to effective therapy and more accurate identification of patients at greatest risk.
